Isoxicam

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8XU734C4NG. European Medicines Agency schedules Isoxicam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08344MIG. Isoxicam generally arises in the molecular formula C14H13N3O5S. The term ISOXICAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, no. 10 1974, list 14.) ISOXICAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isoxicam under HS 29349990 and SITC 51579. As of Q4 2014, ISOXICAM remains the US FDA Preferred Term for this commodity. Isoxicam bears US NLM identifiers UMLS ID C0064104 and NCI Concept Code C80558. SMILES: S1(=O)(=O)N(/C(=C(/O)NC2NOC(C2)C)C(=O)C2C1CCCC2)C.